EGFR-targeted agents and paronychia: a FAERS-based real-world pharmacovigilance analysis - PubMed
5 hours ago
- #Pharmacovigilance
- #EGFR inhibitors
- #Paronychia
- Study focuses on EGFR-targeted agents and their association with paronychia.
- Utilizes the FDA Adverse Event Reporting System (FAERS) for pharmacovigilance analysis.
- Highlights dermatologic adverse events related to epidermal growth factor receptor inhibitors (EGFR).
- Keywords include paronychia and pharmacovigilance.